Domestic Raw Material Supply for Milbemycin Oxime API

The contract pertains to the supply of domestically sourced precursor chemicals or raw materials necessary for the synthesis of Milbemycin Oxime, ensuring compliance with the Buy American Act and Berry Amendment. This subcontract is being issued by the Department of Defense through the Medical Supply Chain Pharmaceutical FSA, focusing on adherence to stringent domestic sourcing requirements. The contract falls under NAICS code 325199, which relates to the pharmaceutical manufacturing industry. The solicitation for this subcontract was posted on May 27, 2026, with a response deadline set for June 2, 2026. The place of performance is indicated as APO with a postal code of 09227-0000, which typically corresponds to military or overseas locations serviced by Army Post Office logistics. The procurement is aimed at securing reliable, compliant raw materials to support the production of active pharmaceutical ingredients (API) for Milbemycin Oxime, a drug utilized within military pharmaceutical supply chains. Interested parties are directed to view further solicitation details through the provided Department of Defense procurement website link.